Evaluating skin symptoms in dermatomyositis patients
Evaluation of Clinical Responsiveness Using the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)
This study is trying to see how skin symptoms affect people with dermatomyositis and how they respond to treatment using a special scoring system.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Pennsylvania Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Trial ID | NCT02945345 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on assessing the clinical responsiveness of patients with dermatomyositis using the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI). Conducted at the University of Pennsylvania, it utilizes a comprehensive database that collects valuable information on disease processes, psychological responses, treatments, and quality of life. The CDASI serves as a validated outcome measure to evaluate the clinical course and impact of dermatomyositis on patients' lives. The ongoing nature of this database allows for continuous insights into the condition and its management.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old diagnosed with cutaneous dermatomyositis.
Not a fit: Patients without cutaneous dermatomyositis or those who are cognitively impaired may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of dermatomyositis and improve treatment strategies, ultimately leading to better patient outcomes.
How similar studies have performed: Other studies utilizing similar assessment tools have shown promise in improving understanding and management of dermatomyositis, indicating a potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Gender/Age: Males or females above 18 years old * Diagnosis: Cutaneous Dermatomyositis * Subjects able to give informed consent Exclusion Criteria: * Subjects without cutaneous DM * Penn employees * Penn students * Cognitively impaired persons
Where this trial is running
Philadelphia, Pennsylvania
- Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania, United States (Recruiting)
Study contacts
- Study coordinator: Victoria Werth, MD
- Email: werth@pennmedicine.upenn.edu
- Phone: 215-615-2940
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.